滤失控制与变粘酸深穿透酸压工艺技术的应用

酸滤失是制约酸蚀缝长延伸的重要因素之一,滤失控制是深穿透酸压工艺成功与否的关键所在。概述了酸滤失的特征及其控制技术的发展过程,着重介绍了90年代末引进国内投入现场应用的变粘酸技术。国内外实践表明变粘酸比目前普遍使用的胶凝酸体系液体效率更高,增产效果更理想,该技术的引进和国产化必将促进国内油气田深穿透酸压工艺技术水平跃上一个新台阶。     

Pitting corrosion of Cr–Mn–N steel in sulphuric acid media

The resistance to pitting corrosion of austenitic stainless steel Cr18Mn12N has been studied in model solutions of sulphuric acid (0.5 m) containing chloride ions (0.5 m). The cyclic potentiodynamic method has been employed to investigate the effects of chloride ions and agitation rate on the pitting and repassivation potentials. Electron and optical microscopy, electron diffraction spectroscopy and atomic absorption spectrometry have been used to detect the surface sites for pit formation and the growth of pit nuclei. The results obtained with chromium–manganese–nitrogen steel have been compared with those of austenitic Cr18Ni9 stainless steel. A similarity in pit initiation is established, while steel composition exhibits no significant effect. Cr18Mn12N steel is less prone to repassivation as compared with Cr18Ni9 steel.     

丙烯酰胺-二甲基二烯丙基氯化铵反相微乳液体系的制备及表征

采用石油醚为连续相、失水山梨糖醇酐单油酸酯(Span80)和聚氧乙烯失水山梨醇单硬脂酸酯(Tween80)为复合乳化剂、正己醇为助乳化剂,建立了丙烯酰胺(AM)和二甲基二烯丙基氯化铵(DMDAAC)反相微乳液体系。使用Zeta电位/粒度/相对分子质量分析仪对该体系的形成及聚合过程中乳胶粒子粒径及其分布进行了测试。实验结果表明,当体系达到微乳液状态时,体系主要由10~100nm的单体微珠及少量粒径小于10nm的胶束组成;随聚合过程的进行,胶束消失,乳胶粒子体积增大。乳胶粒子体积的增大主要是通过扩散和碰撞两种机理完成的。最佳的复合乳化剂亲水-亲油平衡值为8.045,复合乳化剂在油相中的质量分数为33%,助乳化剂在油相中的质量分数为1.6%。在此条件下达到微乳液状态时的水相增容体积最大。     

"牺牲"阳极法合成乙醇钽研究

研究了“牺牲“阳极法电化学合成乙醇钽过程中,添加剂种类与浓度、电解液温度、阴阳极极距和电流密度的影响.选取最佳合成条件为:四甲基氯化铵0.04 mol/L,温度为电解液的沸腾温度,极距约2 cm,电流密度220 A/m2.电合成的混合液经常压蒸馏和减压蒸馏,得到产品用红外光谱、拉曼光谱和元素分析进行表征,确定了产品为乙醇钽.电合成的电流效率大于95%,产品蒸馏时钽的直收率82.8%.     

氯乙烯合成用无汞触媒的研究与应用

利用活性炭的强吸附能力和锡的催化性能,在活性炭上负载氯化亚锡,制备了负载型氯乙烯合成触媒。研究了不同温度、反应时间和乙烘流量下,触媒的使用寿命和乙烘的转化率。分析了氯化亚锡作为活性组分的优缺点。     

高风电渗透率下考虑需求侧管理策略的智能微电网调度方法

提出了一种高风电渗透率下考虑需求侧管理策略的智能微电网调度方法。首先,考虑经济、环境成本指标、清洁能源就地消纳量以及可中断负荷和可转移负荷策略,建立了多目标优化调度模型。然后,引入ε约束法生成Pareto前沿解集,利用归一化方法求出最优折衷解。最后,基于24节点配电系统对所提方法进行分析验证。算例结果表明:建立的多目标优化模型能够有效提升清洁能源的消纳率,提高调度方案经济性,同时有效降低发电污染排放。采用的需求侧管理策略能够有效平抑负荷波动,达到削峰填谷的目的。     

Improving antibacterial,biocompatible, and reusable properties of polyvinyl chloride via the addition of aluminum alkoxides

Global bacterial infections associated with conventional polyvinyl chloride (PVC) medical devices place a heavy burden on healthcare systems and thus it will be desirable if medical devices are made from antimicrobial PVC. There are numerous studies focusing on polymer surface modifications to either leach antimicrobial agents or kill pathogenic microbes upon direct contact. In this work, mannitol fumarate ester-based aluminum metal alkoxide (MFE-Al) additive was developed to confer simultaneously improved antibacterial property and enhanced high temperature sterilization resistance of the resultant PVC. Data obtained confirm that the MFE-Al stabilized PVC sheets significantly inhibit 98% bacterial growth. They also show biocompatibility with cultured H9C2 cardiomyocytes and hemocompatibility in vitro. Dry heat sterilization is generally not suitable for PVC medical wares due to their poor thermal compatibility. Surprisingly, our antimicrobial-biocompatible PVC can maintain stability at 180°C for 90 min. Such a high thermal stability indicates the MFE-Al stabilized PVC can endure 90 cycles of dry-heat sterilization without significant damage. This study may provide a solution to reduce PVC medical waste for a maximum benefit without compromising human health or the environment.     

Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles

Phosphodiesterase 7 (PDE7) is an enzyme responsible for the degradation of cyclic adenosine monophosphate (cAMP), an important cellular messenger. PDE7’s role in neurotransmission, expression profile in the brain and the druggability of other phosphodiesterases have motivated the search for potent inhibitors to treat neurodegenerative and inflammatory diseases. Different heterocyclic compounds have been described over the years; among them, phenyl-2-thioxo-(1H)-quinazolin-4-one, called S14, has shown very promising results in different in vitro and in vivo studies. Recently, polymeric nanoparticles have been used as new formulations to target specific organs and produce controlled release of certain drugs. In this work, we describe poly(lactic-co-glycolic acid) (PLGA)-based polymeric nanoparticles loaded with S14. Their preparation, optimization, characterization and in vivo drug release profile are here presented as an effort to improve pharmacokinetic properties of this interesting PDE7 inhibitor.